nodes	percent_of_prediction	percent_of_DWPC	metapath
Amantadine—multiple sclerosis—Amitriptyline—migraine	0.251	0.46	CpDpCtD
Amantadine—multiple sclerosis—Gabapentin—migraine	0.162	0.296	CpDpCtD
Amantadine—Parkinson's disease—Gabapentin—migraine	0.133	0.244	CpDpCtD
Amantadine—SIGMAR1—Amitriptyline—migraine	0.0923	0.343	CbGbCtD
Amantadine—SLC22A2—Propranolol—migraine	0.0556	0.207	CbGbCtD
Amantadine—DRD2—Amitriptyline—migraine	0.0334	0.124	CbGbCtD
Amantadine—SLC22A1—Verapamil—migraine	0.0331	0.123	CbGbCtD
Amantadine—ABCB1—Timolol—migraine	0.0166	0.0618	CbGbCtD
Amantadine—ABCB1—Propranolol—migraine	0.0148	0.055	CbGbCtD
Amantadine—ABCB1—Amitriptyline—migraine	0.0128	0.0476	CbGbCtD
Amantadine—ABCB1—Verapamil—migraine	0.0102	0.0378	CbGbCtD
Amantadine—GRIN2C—nerve—migraine	0.00286	0.067	CbGeAlD
Amantadine—DDC—pineal body—migraine	0.00254	0.0596	CbGeAlD
Amantadine—GRIN2B—nerve—migraine	0.00226	0.053	CbGeAlD
Amantadine—GRIN2A—nerve—migraine	0.00197	0.0463	CbGeAlD
Amantadine—DDC—nerve—migraine	0.00185	0.0433	CbGeAlD
Amantadine—GRIN2C—brainstem—migraine	0.00123	0.0288	CbGeAlD
Amantadine—GRIN2D—brainstem—migraine	0.00114	0.0268	CbGeAlD
Amantadine—GRIN1—brainstem—migraine	0.00102	0.0238	CbGeAlD
Amantadine—GRIN2B—brainstem—migraine	0.00097	0.0228	CbGeAlD
Amantadine—MAOB—nerve—migraine	0.000949	0.0223	CbGeAlD
Amantadine—GRIN2A—brainstem—migraine	0.000848	0.0199	CbGeAlD
Amantadine—DRD2—nerve—migraine	0.000801	0.0188	CbGeAlD
Amantadine—DDC—brainstem—migraine	0.000792	0.0186	CbGeAlD
Amantadine—SLC22A2—trigeminal ganglion—migraine	0.000737	0.0173	CbGeAlD
Amantadine—GRIN2C—head—migraine	0.000678	0.0159	CbGeAlD
Amantadine—GRIN2C—nervous system—migraine	0.000643	0.0151	CbGeAlD
Amantadine—GRIN2D—head—migraine	0.00063	0.0148	CbGeAlD
Amantadine—GRIN2C—central nervous system—migraine	0.000619	0.0145	CbGeAlD
Amantadine—GRIN2C—cerebellum—migraine	0.000605	0.0142	CbGeAlD
Amantadine—GRIN2D—nervous system—migraine	0.000598	0.014	CbGeAlD
Amantadine—GRIN3A—head—migraine	0.000593	0.0139	CbGeAlD
Amantadine—GRIN2D—central nervous system—migraine	0.000575	0.0135	CbGeAlD
Amantadine—GRIN2C—Alzheimers Disease—LRP1—migraine	0.000573	0.0268	CbGpPWpGaD
Amantadine—GRIN2D—cerebellum—migraine	0.000562	0.0132	CbGeAlD
Amantadine—GRIN3A—nervous system—migraine	0.000562	0.0132	CbGeAlD
Amantadine—GRIN1—head—migraine	0.000562	0.0132	CbGeAlD
Amantadine—GRIN2C—Neuronal System—KCNK18—migraine	0.000545	0.0255	CbGpPWpGaD
Amantadine—GRIN3A—central nervous system—migraine	0.000541	0.0127	CbGeAlD
Amantadine—GRIN2B—head—migraine	0.000536	0.0126	CbGeAlD
Amantadine—GRIN1—nervous system—migraine	0.000533	0.0125	CbGeAlD
Amantadine—GRIN2D—Alzheimers Disease—LRP1—migraine	0.000532	0.025	CbGpPWpGaD
Amantadine—GRIN1—central nervous system—migraine	0.000513	0.012	CbGeAlD
Amantadine—GRIN2B—nervous system—migraine	0.000508	0.0119	CbGeAlD
Amantadine—GRIN2D—Neuronal System—KCNK18—migraine	0.000506	0.0237	CbGpPWpGaD
Amantadine—GRIN1—cerebellum—migraine	0.000501	0.0118	CbGeAlD
Amantadine—GRIN2C—brain—migraine	0.000491	0.0115	CbGeAlD
Amantadine—GRIN2B—central nervous system—migraine	0.000489	0.0115	CbGeAlD
Amantadine—SIGMAR1—trigeminal ganglion—migraine	0.000481	0.0113	CbGeAlD
Amantadine—GRIN2B—cerebellum—migraine	0.000478	0.0112	CbGeAlD
Amantadine—GRIN2A—head—migraine	0.000468	0.011	CbGeAlD
Amantadine—MAOB—trigeminal ganglion—migraine	0.00046	0.0108	CbGeAlD
Amantadine—GRIN2D—brain—migraine	0.000457	0.0107	CbGeAlD
Amantadine—DDC—SIDS Susceptibility Pathways—ATP1A3—migraine	0.000454	0.0213	CbGpPWpGaD
Amantadine—GRIN2A—nervous system—migraine	0.000444	0.0104	CbGeAlD
Amantadine—DDC—head—migraine	0.000438	0.0103	CbGeAlD
Amantadine—GRIN2A—Alzheimers Disease—LRP1—migraine	0.000437	0.0205	CbGpPWpGaD
Amantadine—DRD2—Monoamine GPCRs—HTR1D—migraine	0.00043	0.0201	CbGpPWpGaD
Amantadine—GRIN3A—brain—migraine	0.000429	0.0101	CbGeAlD
Amantadine—GRIN2A—central nervous system—migraine	0.000428	0.01	CbGeAlD
Amantadine—GRIN2A—cerebellum—migraine	0.000418	0.0098	CbGeAlD
Amantadine—GRIN2A—Neuronal System—KCNK18—migraine	0.000416	0.0195	CbGpPWpGaD
Amantadine—DDC—nervous system—migraine	0.000415	0.00973	CbGeAlD
Amantadine—MAOB—brainstem—migraine	0.000407	0.00956	CbGeAlD
Amantadine—GRIN1—brain—migraine	0.000407	0.00955	CbGeAlD
Amantadine—DRD2—Monoamine GPCRs—HTR2B—migraine	0.0004	0.0187	CbGpPWpGaD
Amantadine—DDC—central nervous system—migraine	0.0004	0.00937	CbGeAlD
Amantadine—GRIN1—SIDS Susceptibility Pathways—ATP1A3—migraine	0.00039	0.0183	CbGpPWpGaD
Amantadine—GRIN2B—brain—migraine	0.000388	0.00911	CbGeAlD
Amantadine—DDC—SIDS Susceptibility Pathways—HTR3A—migraine	0.000386	0.0181	CbGpPWpGaD
Amantadine—GRIN1—Alzheimers Disease—LRP1—migraine	0.000381	0.0179	CbGpPWpGaD
Amantadine—GRIN2B—Alzheimers Disease—LRP1—migraine	0.000372	0.0174	CbGpPWpGaD
Amantadine—GRIN1—Neuronal System—KCNK18—migraine	0.000363	0.017	CbGpPWpGaD
Amantadine—DRD2—Amine ligand-binding receptors—HTR1D—migraine	0.000361	0.0169	CbGpPWpGaD
Amantadine—GRIN2B—Neuronal System—KCNK18—migraine	0.000354	0.0166	CbGpPWpGaD
Amantadine—GRIN2C—Transmission across Chemical Synapses—CACNA1A—migraine	0.000347	0.0163	CbGpPWpGaD
Amantadine—DRD2—brainstem—migraine	0.000344	0.00807	CbGeAlD
Amantadine—GRIN2A—brain—migraine	0.000339	0.00796	CbGeAlD
Amantadine—DRD2—Amine ligand-binding receptors—HTR2B—migraine	0.000336	0.0157	CbGpPWpGaD
Amantadine—MAOB—cardiovascular system—migraine	0.000333	0.0078	CbGeAlD
Amantadine—GRIN1—SIDS Susceptibility Pathways—HTR3A—migraine	0.000332	0.0155	CbGpPWpGaD
Amantadine—GRIN2D—Transmission across Chemical Synapses—CACNA1A—migraine	0.000323	0.0151	CbGpPWpGaD
Amantadine—DDC—brain—migraine	0.000317	0.00744	CbGeAlD
Amantadine—GRIN1—Mecp2 and Associated Rett Syndrome—BDNF—migraine	0.000284	0.0133	CbGpPWpGaD
Amantadine—ABCB1—blood vessel—migraine	0.000272	0.00638	CbGeAlD
Amantadine—GRIN2C—Neuronal System—CACNA1A—migraine	0.000266	0.0125	CbGpPWpGaD
Amantadine—GRIN2A—Transmission across Chemical Synapses—CACNA1A—migraine	0.000265	0.0124	CbGpPWpGaD
Amantadine—DRD2—Monoamine GPCRs—HTR1B—migraine	0.00026	0.0122	CbGpPWpGaD
Amantadine—SLC22A1—head—migraine	0.000255	0.00597	CbGeAlD
Amantadine—DRD2—Monoamine GPCRs—HTR1A—migraine	0.000251	0.0117	CbGpPWpGaD
Amantadine—GRIN2D—Neuronal System—CACNA1A—migraine	0.000247	0.0116	CbGpPWpGaD
Amantadine—DRD2—Monoamine GPCRs—HTR2C—migraine	0.000242	0.0113	CbGpPWpGaD
Amantadine—SLC22A1—nervous system—migraine	0.000241	0.00566	CbGeAlD
Amantadine—SLC22A1—central nervous system—migraine	0.000232	0.00545	CbGeAlD
Amantadine—GRIN1—Transmission across Chemical Synapses—CACNA1A—migraine	0.000231	0.0108	CbGpPWpGaD
Amantadine—GRIN2B—Transmission across Chemical Synapses—CACNA1A—migraine	0.000225	0.0106	CbGpPWpGaD
Amantadine—MAOB—head—migraine	0.000225	0.00528	CbGeAlD
Amantadine—DRD2—Amine ligand-binding receptors—HTR1B—migraine	0.000219	0.0103	CbGpPWpGaD
Amantadine—GRIN1—Axon guidance—SCN1A—migraine	0.000217	0.0102	CbGpPWpGaD
Amantadine—MAOB—nervous system—migraine	0.000213	0.00501	CbGeAlD
Amantadine—DRD2—Monoamine GPCRs—HTR7—migraine	0.000212	0.00994	CbGpPWpGaD
Amantadine—GRIN2B—Axon guidance—SCN1A—migraine	0.000212	0.00993	CbGpPWpGaD
Amantadine—DRD2—Amine ligand-binding receptors—HTR1A—migraine	0.000211	0.00988	CbGpPWpGaD
Amantadine—SIGMAR1—cerebellum—migraine	0.00021	0.00492	CbGeAlD
Amantadine—MAOB—central nervous system—migraine	0.000206	0.00482	CbGeAlD
Amantadine—DRD2—Amine ligand-binding receptors—HTR2C—migraine	0.000204	0.00954	CbGpPWpGaD
Amantadine—GRIN2A—Neuronal System—CACNA1A—migraine	0.000203	0.00952	CbGpPWpGaD
Amantadine—MAOB—cerebellum—migraine	0.000201	0.00471	CbGeAlD
Amantadine—DRD2—head—migraine	0.00019	0.00446	CbGeAlD
Amantadine—SLC22A2—Neuronal System—KCNK18—migraine	0.000189	0.00884	CbGpPWpGaD
Amantadine—GRIN1—Axon guidance—SCN2A—migraine	0.000185	0.00866	CbGpPWpGaD
Amantadine—SLC22A1—brain—migraine	0.000185	0.00433	CbGeAlD
Amantadine—Decreased appetite—Propranolol—migraine	0.000184	0.00152	CcSEcCtD
Amantadine—Pruritus—Amitriptyline—migraine	0.000184	0.00152	CcSEcCtD
Amantadine—DDC—SIDS Susceptibility Pathways—HTR1A—migraine	0.000184	0.0086	CbGpPWpGaD
Amantadine—Photosensitivity reaction—Gabapentin—migraine	0.000183	0.00152	CcSEcCtD
Amantadine—Gastrointestinal disorder—Propranolol—migraine	0.000182	0.00151	CcSEcCtD
Amantadine—Fatigue—Propranolol—migraine	0.000182	0.00151	CcSEcCtD
Amantadine—Hypotension—Verapamil—migraine	0.000182	0.0015	CcSEcCtD
Amantadine—Eye disorder—Valproic Acid—migraine	0.000181	0.0015	CcSEcCtD
Amantadine—DDC—SIDS Susceptibility Pathways—TAC1—migraine	0.000181	0.00847	CbGpPWpGaD
Amantadine—Constipation—Propranolol—migraine	0.000181	0.0015	CcSEcCtD
Amantadine—Liver function test abnormal—Topiramate—migraine	0.000181	0.00149	CcSEcCtD
Amantadine—GRIN2B—Axon guidance—SCN2A—migraine	0.00018	0.00845	CbGpPWpGaD
Amantadine—DRD2—nervous system—migraine	0.00018	0.00423	CbGeAlD
Amantadine—Agranulocytosis—Timolol—migraine	0.00018	0.00149	CcSEcCtD
Amantadine—Orthostatic hypotension—Topiramate—migraine	0.000179	0.00148	CcSEcCtD
Amantadine—DRD2—Amine ligand-binding receptors—HTR7—migraine	0.000178	0.00835	CbGpPWpGaD
Amantadine—Diarrhoea—Amitriptyline—migraine	0.000178	0.00147	CcSEcCtD
Amantadine—DDC—SIDS Susceptibility Pathways—SLC6A4—migraine	0.000177	0.00831	CbGpPWpGaD
Amantadine—GRIN1—Neuronal System—CACNA1A—migraine	0.000177	0.0083	CbGpPWpGaD
Amantadine—Angiopathy—Valproic Acid—migraine	0.000176	0.00146	CcSEcCtD
Amantadine—Insomnia—Verapamil—migraine	0.000176	0.00146	CcSEcCtD
Amantadine—SLC22A1—Neuronal System—KCNK18—migraine	0.000176	0.00824	CbGpPWpGaD
Amantadine—Mediastinal disorder—Valproic Acid—migraine	0.000175	0.00145	CcSEcCtD
Amantadine—Paraesthesia—Verapamil—migraine	0.000175	0.00144	CcSEcCtD
Amantadine—DRD2—central nervous system—migraine	0.000173	0.00407	CbGeAlD
Amantadine—Arrhythmia—Valproic Acid—migraine	0.000173	0.00143	CcSEcCtD
Amantadine—Dyspnoea—Verapamil—migraine	0.000173	0.00143	CcSEcCtD
Amantadine—Somnolence—Verapamil—migraine	0.000173	0.00143	CcSEcCtD
Amantadine—GRIN2B—Neuronal System—CACNA1A—migraine	0.000173	0.00809	CbGpPWpGaD
Amantadine—Hallucination—Timolol—migraine	0.000172	0.00142	CcSEcCtD
Amantadine—Dizziness—Amitriptyline—migraine	0.000172	0.00142	CcSEcCtD
Amantadine—Alopecia—Valproic Acid—migraine	0.000171	0.00142	CcSEcCtD
Amantadine—Dyspepsia—Verapamil—migraine	0.000171	0.00142	CcSEcCtD
Amantadine—SIGMAR1—brain—migraine	0.00017	0.004	CbGeAlD
Amantadine—Oedema peripheral—Timolol—migraine	0.00017	0.00141	CcSEcCtD
Amantadine—Mental disorder—Valproic Acid—migraine	0.00017	0.00141	CcSEcCtD
Amantadine—DRD2—cerebellum—migraine	0.00017	0.00398	CbGeAlD
Amantadine—Dysphagia—Topiramate—migraine	0.000169	0.0014	CcSEcCtD
Amantadine—Malnutrition—Valproic Acid—migraine	0.000169	0.0014	CcSEcCtD
Amantadine—ABCB1—trigeminal ganglion—migraine	0.000168	0.00394	CbGeAlD
Amantadine—Fatigue—Verapamil—migraine	0.000168	0.00139	CcSEcCtD
Amantadine—Body temperature increased—Propranolol—migraine	0.000167	0.00138	CcSEcCtD
Amantadine—Visual impairment—Timolol—migraine	0.000166	0.00138	CcSEcCtD
Amantadine—Constipation—Verapamil—migraine	0.000166	0.00138	CcSEcCtD
Amantadine—Tension—Valproic Acid—migraine	0.000166	0.00137	CcSEcCtD
Amantadine—Vomiting—Amitriptyline—migraine	0.000165	0.00137	CcSEcCtD
Amantadine—Sweating increased—Topiramate—migraine	0.000165	0.00136	CcSEcCtD
Amantadine—Nervousness—Valproic Acid—migraine	0.000164	0.00136	CcSEcCtD
Amantadine—Rash—Amitriptyline—migraine	0.000164	0.00135	CcSEcCtD
Amantadine—Dermatitis—Amitriptyline—migraine	0.000163	0.00135	CcSEcCtD
Amantadine—MAOB—brain—migraine	0.000163	0.00383	CbGeAlD
Amantadine—Headache—Amitriptyline—migraine	0.000163	0.00135	CcSEcCtD
Amantadine—Eye disorder—Timolol—migraine	0.000161	0.00134	CcSEcCtD
Amantadine—Cardiac disorder—Timolol—migraine	0.00016	0.00133	CcSEcCtD
Amantadine—Feeling abnormal—Verapamil—migraine	0.00016	0.00133	CcSEcCtD
Amantadine—Hallucination—Gabapentin—migraine	0.00016	0.00132	CcSEcCtD
Amantadine—Vision blurred—Valproic Acid—migraine	0.000159	0.00132	CcSEcCtD
Amantadine—Urinary tract disorder—Gabapentin—migraine	0.000159	0.00131	CcSEcCtD
Amantadine—Oedema peripheral—Gabapentin—migraine	0.000158	0.00131	CcSEcCtD
Amantadine—Tremor—Valproic Acid—migraine	0.000158	0.00131	CcSEcCtD
Amantadine—Neutropenia—Topiramate—migraine	0.000158	0.00131	CcSEcCtD
Amantadine—GRIN1—SIDS Susceptibility Pathways—HTR1A—migraine	0.000158	0.00739	CbGpPWpGaD
Amantadine—Urethral disorder—Gabapentin—migraine	0.000158	0.00131	CcSEcCtD
Amantadine—Angiopathy—Timolol—migraine	0.000157	0.0013	CcSEcCtD
Amantadine—Hypersensitivity—Propranolol—migraine	0.000156	0.00129	CcSEcCtD
Amantadine—Mediastinal disorder—Timolol—migraine	0.000156	0.00129	CcSEcCtD
Amantadine—GRIN1—SIDS Susceptibility Pathways—TAC1—migraine	0.000155	0.00728	CbGpPWpGaD
Amantadine—Agitation—Valproic Acid—migraine	0.000155	0.00128	CcSEcCtD
Amantadine—GRIN1—Developmental Biology—SCN1A—migraine	0.000155	0.00727	CbGpPWpGaD
Amantadine—Visual impairment—Gabapentin—migraine	0.000155	0.00128	CcSEcCtD
Amantadine—Photosensitivity reaction—Topiramate—migraine	0.000154	0.00128	CcSEcCtD
Amantadine—Arrhythmia—Timolol—migraine	0.000154	0.00128	CcSEcCtD
Amantadine—Nausea—Amitriptyline—migraine	0.000154	0.00128	CcSEcCtD
Amantadine—Alopecia—Timolol—migraine	0.000153	0.00126	CcSEcCtD
Amantadine—GRIN1—SIDS Susceptibility Pathways—SLC6A4—migraine	0.000152	0.00714	CbGpPWpGaD
Amantadine—Asthenia—Propranolol—migraine	0.000152	0.00126	CcSEcCtD
Amantadine—Mental disorder—Timolol—migraine	0.000151	0.00125	CcSEcCtD
Amantadine—GRIN2B—Developmental Biology—SCN1A—migraine	0.000151	0.00709	CbGpPWpGaD
Amantadine—Leukopenia—Valproic Acid—migraine	0.000151	0.00125	CcSEcCtD
Amantadine—Malnutrition—Timolol—migraine	0.00015	0.00124	CcSEcCtD
Amantadine—Eye disorder—Gabapentin—migraine	0.00015	0.00124	CcSEcCtD
Amantadine—Cardiac disorder—Gabapentin—migraine	0.000149	0.00124	CcSEcCtD
Amantadine—Palpitations—Valproic Acid—migraine	0.000149	0.00124	CcSEcCtD
Amantadine—DRD2—Monoamine GPCRs—HTR2A—migraine	0.000149	0.00696	CbGpPWpGaD
Amantadine—DDC—Circadian rythm related genes—NPS—migraine	0.000148	0.00692	CbGpPWpGaD
Amantadine—Tension—Timolol—migraine	0.000148	0.00122	CcSEcCtD
Amantadine—Nervousness—Timolol—migraine	0.000146	0.00121	CcSEcCtD
Amantadine—Hypertension—Valproic Acid—migraine	0.000146	0.00121	CcSEcCtD
Amantadine—Mediastinal disorder—Gabapentin—migraine	0.000145	0.0012	CcSEcCtD
Amantadine—DDC—Circadian rythm related genes—SLC6A4—migraine	0.000145	0.00678	CbGpPWpGaD
Amantadine—Diarrhoea—Propranolol—migraine	0.000145	0.0012	CcSEcCtD
Amantadine—Anxiety—Valproic Acid—migraine	0.000143	0.00119	CcSEcCtD
Amantadine—Hypersensitivity—Verapamil—migraine	0.000143	0.00119	CcSEcCtD
Amantadine—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—migraine	0.000143	0.00118	CcSEcCtD
Amantadine—Alopecia—Gabapentin—migraine	0.000142	0.00118	CcSEcCtD
Amantadine—Vision blurred—Timolol—migraine	0.000142	0.00117	CcSEcCtD
Amantadine—Mental disorder—Gabapentin—migraine	0.000141	0.00117	CcSEcCtD
Amantadine—Agranulocytosis—Topiramate—migraine	0.000141	0.00116	CcSEcCtD
Amantadine—Dry mouth—Valproic Acid—migraine	0.000141	0.00116	CcSEcCtD
Amantadine—Malnutrition—Gabapentin—migraine	0.00014	0.00116	CcSEcCtD
Amantadine—Dizziness—Propranolol—migraine	0.00014	0.00116	CcSEcCtD
Amantadine—Asthenia—Verapamil—migraine	0.000139	0.00115	CcSEcCtD
Amantadine—Confusional state—Valproic Acid—migraine	0.000139	0.00115	CcSEcCtD
Amantadine—GRIN1—Spinal Cord Injury—BDNF—migraine	0.000138	0.00648	CbGpPWpGaD
Amantadine—Anaphylactic shock—Valproic Acid—migraine	0.000138	0.00114	CcSEcCtD
Amantadine—Oedema—Valproic Acid—migraine	0.000138	0.00114	CcSEcCtD
Amantadine—DRD2—brain—migraine	0.000138	0.00323	CbGeAlD
Amantadine—Pruritus—Verapamil—migraine	0.000138	0.00114	CcSEcCtD
Amantadine—Tension—Gabapentin—migraine	0.000137	0.00114	CcSEcCtD
Amantadine—Nervousness—Gabapentin—migraine	0.000136	0.00113	CcSEcCtD
Amantadine—Nervous system disorder—Valproic Acid—migraine	0.000135	0.00112	CcSEcCtD
Amantadine—Hallucination—Topiramate—migraine	0.000135	0.00111	CcSEcCtD
Amantadine—Tachycardia—Valproic Acid—migraine	0.000135	0.00111	CcSEcCtD
Amantadine—Vomiting—Propranolol—migraine	0.000134	0.00111	CcSEcCtD
Amantadine—Skin disorder—Valproic Acid—migraine	0.000134	0.00111	CcSEcCtD
Amantadine—Urinary tract disorder—Topiramate—migraine	0.000134	0.00111	CcSEcCtD
Amantadine—Oedema peripheral—Topiramate—migraine	0.000133	0.0011	CcSEcCtD
Amantadine—Hyperhidrosis—Valproic Acid—migraine	0.000133	0.0011	CcSEcCtD
Amantadine—Rash—Propranolol—migraine	0.000133	0.0011	CcSEcCtD
Amantadine—Dermatitis—Propranolol—migraine	0.000133	0.0011	CcSEcCtD
Amantadine—Diarrhoea—Verapamil—migraine	0.000133	0.0011	CcSEcCtD
Amantadine—Palpitations—Timolol—migraine	0.000133	0.0011	CcSEcCtD
Amantadine—Urethral disorder—Topiramate—migraine	0.000133	0.0011	CcSEcCtD
Amantadine—Vision blurred—Gabapentin—migraine	0.000132	0.00109	CcSEcCtD
Amantadine—GRIN1—Developmental Biology—SCN2A—migraine	0.000132	0.00618	CbGpPWpGaD
Amantadine—Anorexia—Valproic Acid—migraine	0.000131	0.00109	CcSEcCtD
Amantadine—Tremor—Gabapentin—migraine	0.000131	0.00109	CcSEcCtD
Amantadine—Visual impairment—Topiramate—migraine	0.00013	0.00108	CcSEcCtD
Amantadine—Hypertension—Timolol—migraine	0.00013	0.00107	CcSEcCtD
Amantadine—Hypotension—Valproic Acid—migraine	0.000129	0.00107	CcSEcCtD
Amantadine—DDC—SIDS Susceptibility Pathways—BDNF—migraine	0.000129	0.00603	CbGpPWpGaD
Amantadine—Agitation—Gabapentin—migraine	0.000129	0.00107	CcSEcCtD
Amantadine—GRIN2B—Developmental Biology—SCN2A—migraine	0.000129	0.00603	CbGpPWpGaD
Amantadine—Dizziness—Verapamil—migraine	0.000129	0.00106	CcSEcCtD
Amantadine—Anxiety—Timolol—migraine	0.000128	0.00106	CcSEcCtD
Amantadine—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	0.000127	0.00105	CcSEcCtD
Amantadine—DDC—Circadian rythm related genes—HTR7—migraine	0.000127	0.00594	CbGpPWpGaD
Amantadine—Eye disorder—Topiramate—migraine	0.000126	0.00105	CcSEcCtD
Amantadine—Cardiac disorder—Topiramate—migraine	0.000126	0.00104	CcSEcCtD
Amantadine—Nausea—Propranolol—migraine	0.000126	0.00104	CcSEcCtD
Amantadine—Leukopenia—Gabapentin—migraine	0.000125	0.00104	CcSEcCtD
Amantadine—Dry mouth—Timolol—migraine	0.000125	0.00104	CcSEcCtD
Amantadine—DRD2—Amine ligand-binding receptors—HTR2A—migraine	0.000125	0.00585	CbGpPWpGaD
Amantadine—Insomnia—Valproic Acid—migraine	0.000125	0.00103	CcSEcCtD
Amantadine—Paraesthesia—Valproic Acid—migraine	0.000124	0.00102	CcSEcCtD
Amantadine—Palpitations—Gabapentin—migraine	0.000124	0.00102	CcSEcCtD
Amantadine—Confusional state—Timolol—migraine	0.000124	0.00102	CcSEcCtD
Amantadine—Vomiting—Verapamil—migraine	0.000124	0.00102	CcSEcCtD
Amantadine—Dyspnoea—Valproic Acid—migraine	0.000123	0.00102	CcSEcCtD
Amantadine—Angiopathy—Topiramate—migraine	0.000123	0.00102	CcSEcCtD
Amantadine—Oedema—Timolol—migraine	0.000123	0.00102	CcSEcCtD
Amantadine—Anaphylactic shock—Timolol—migraine	0.000123	0.00102	CcSEcCtD
Amantadine—Rash—Verapamil—migraine	0.000123	0.00101	CcSEcCtD
Amantadine—Somnolence—Valproic Acid—migraine	0.000123	0.00101	CcSEcCtD
Amantadine—Dermatitis—Verapamil—migraine	0.000122	0.00101	CcSEcCtD
Amantadine—Mediastinal disorder—Topiramate—migraine	0.000122	0.00101	CcSEcCtD
Amantadine—Headache—Verapamil—migraine	0.000122	0.00101	CcSEcCtD
Amantadine—Dyspepsia—Valproic Acid—migraine	0.000121	0.001	CcSEcCtD
Amantadine—Convulsion—Gabapentin—migraine	0.000121	0.001	CcSEcCtD
Amantadine—ABCB1—cardiovascular system—migraine	0.000121	0.00284	CbGeAlD
Amantadine—Hypertension—Gabapentin—migraine	0.000121	0.001	CcSEcCtD
Amantadine—GRIN1—Developmental Biology—MEF2D—migraine	0.000121	0.00565	CbGpPWpGaD
Amantadine—Nervous system disorder—Timolol—migraine	0.00012	0.000996	CcSEcCtD
Amantadine—SLC22A2—Transmission across Chemical Synapses—CACNA1A—migraine	0.00012	0.00563	CbGpPWpGaD
Amantadine—Decreased appetite—Valproic Acid—migraine	0.00012	0.000992	CcSEcCtD
Amantadine—Alopecia—Topiramate—migraine	0.00012	0.00099	CcSEcCtD
Amantadine—Skin disorder—Timolol—migraine	0.000119	0.000987	CcSEcCtD
Amantadine—Gastrointestinal disorder—Valproic Acid—migraine	0.000119	0.000985	CcSEcCtD
Amantadine—Fatigue—Valproic Acid—migraine	0.000119	0.000984	CcSEcCtD
Amantadine—Anxiety—Gabapentin—migraine	0.000119	0.000983	CcSEcCtD
Amantadine—Hyperhidrosis—Timolol—migraine	0.000119	0.000982	CcSEcCtD
Amantadine—Mental disorder—Topiramate—migraine	0.000119	0.000981	CcSEcCtD
Amantadine—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	0.000118	0.00098	CcSEcCtD
Amantadine—GRIN1—BDNF signaling pathway—BDNF—migraine	0.000118	0.00553	CbGpPWpGaD
Amantadine—Constipation—Valproic Acid—migraine	0.000118	0.000976	CcSEcCtD
Amantadine—Malnutrition—Topiramate—migraine	0.000118	0.000975	CcSEcCtD
Amantadine—GRIN2B—Developmental Biology—MEF2D—migraine	0.000118	0.00551	CbGpPWpGaD
Amantadine—Anorexia—Timolol—migraine	0.000117	0.000968	CcSEcCtD
Amantadine—Dry mouth—Gabapentin—migraine	0.000117	0.000965	CcSEcCtD
Amantadine—Tension—Topiramate—migraine	0.000116	0.000957	CcSEcCtD
Amantadine—Nausea—Verapamil—migraine	0.000115	0.000956	CcSEcCtD
Amantadine—Confusional state—Gabapentin—migraine	0.000115	0.000954	CcSEcCtD
Amantadine—GRIN2B—BDNF signaling pathway—BDNF—migraine	0.000115	0.00539	CbGpPWpGaD
Amantadine—Hypotension—Timolol—migraine	0.000115	0.000949	CcSEcCtD
Amantadine—Nervousness—Topiramate—migraine	0.000114	0.000947	CcSEcCtD
Amantadine—Anaphylactic shock—Gabapentin—migraine	0.000114	0.000946	CcSEcCtD
Amantadine—Oedema—Gabapentin—migraine	0.000114	0.000946	CcSEcCtD
Amantadine—Feeling abnormal—Valproic Acid—migraine	0.000114	0.00094	CcSEcCtD
Amantadine—Nervous system disorder—Gabapentin—migraine	0.000112	0.000928	CcSEcCtD
Amantadine—SLC22A1—Transmission across Chemical Synapses—CACNA1A—migraine	0.000112	0.00525	CbGpPWpGaD
Amantadine—Tachycardia—Gabapentin—migraine	0.000112	0.000923	CcSEcCtD
Amantadine—Vision blurred—Topiramate—migraine	0.000111	0.000919	CcSEcCtD
Amantadine—Skin disorder—Gabapentin—migraine	0.000111	0.000919	CcSEcCtD
Amantadine—Insomnia—Timolol—migraine	0.000111	0.000919	CcSEcCtD
Amantadine—GRIN1—SIDS Susceptibility Pathways—BDNF—migraine	0.000111	0.00518	CbGpPWpGaD
Amantadine—Hyperhidrosis—Gabapentin—migraine	0.00011	0.000914	CcSEcCtD
Amantadine—Tremor—Topiramate—migraine	0.00011	0.000914	CcSEcCtD
Amantadine—Paraesthesia—Timolol—migraine	0.00011	0.000912	CcSEcCtD
Amantadine—Dyspnoea—Timolol—migraine	0.000109	0.000906	CcSEcCtD
Amantadine—Somnolence—Timolol—migraine	0.000109	0.000903	CcSEcCtD
Amantadine—Body temperature increased—Valproic Acid—migraine	0.000109	0.000902	CcSEcCtD
Amantadine—Anorexia—Gabapentin—migraine	0.000109	0.000902	CcSEcCtD
Amantadine—DDC—SIDS Susceptibility Pathways—HTR2A—migraine	0.000109	0.0051	CbGpPWpGaD
Amantadine—Agitation—Topiramate—migraine	0.000108	0.000896	CcSEcCtD
Amantadine—Dyspepsia—Timolol—migraine	0.000108	0.000894	CcSEcCtD
Amantadine—Hypotension—Gabapentin—migraine	0.000107	0.000884	CcSEcCtD
Amantadine—Decreased appetite—Timolol—migraine	0.000107	0.000883	CcSEcCtD
Amantadine—Gastrointestinal disorder—Timolol—migraine	0.000106	0.000877	CcSEcCtD
Amantadine—Fatigue—Timolol—migraine	0.000106	0.000876	CcSEcCtD
Amantadine—Leukopenia—Topiramate—migraine	0.000105	0.000873	CcSEcCtD
Amantadine—Palpitations—Topiramate—migraine	0.000104	0.000862	CcSEcCtD
Amantadine—GRIN2C—Alzheimers Disease—TNF—migraine	0.000104	0.00487	CbGpPWpGaD
Amantadine—Insomnia—Gabapentin—migraine	0.000103	0.000856	CcSEcCtD
Amantadine—Paraesthesia—Gabapentin—migraine	0.000103	0.000849	CcSEcCtD
Amantadine—Convulsion—Topiramate—migraine	0.000102	0.000845	CcSEcCtD
Amantadine—Dyspnoea—Gabapentin—migraine	0.000102	0.000843	CcSEcCtD
Amantadine—Hypertension—Topiramate—migraine	0.000102	0.000842	CcSEcCtD
Amantadine—Somnolence—Gabapentin—migraine	0.000102	0.000841	CcSEcCtD
Amantadine—Hypersensitivity—Valproic Acid—migraine	0.000102	0.000841	CcSEcCtD
Amantadine—Feeling abnormal—Timolol—migraine	0.000101	0.000837	CcSEcCtD
Amantadine—Dyspepsia—Gabapentin—migraine	0.000101	0.000833	CcSEcCtD
Amantadine—Anxiety—Topiramate—migraine	9.99e-05	0.000827	CcSEcCtD
Amantadine—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	9.96e-05	0.000824	CcSEcCtD
Amantadine—Decreased appetite—Gabapentin—migraine	9.93e-05	0.000822	CcSEcCtD
Amantadine—Asthenia—Valproic Acid—migraine	9.89e-05	0.000819	CcSEcCtD
Amantadine—Gastrointestinal disorder—Gabapentin—migraine	9.86e-05	0.000817	CcSEcCtD
Amantadine—Fatigue—Gabapentin—migraine	9.85e-05	0.000815	CcSEcCtD
Amantadine—Dry mouth—Topiramate—migraine	9.81e-05	0.000812	CcSEcCtD
Amantadine—Constipation—Gabapentin—migraine	9.77e-05	0.000809	CcSEcCtD
Amantadine—Pruritus—Valproic Acid—migraine	9.75e-05	0.000807	CcSEcCtD
Amantadine—Body temperature increased—Timolol—migraine	9.7e-05	0.000803	CcSEcCtD
Amantadine—Confusional state—Topiramate—migraine	9.69e-05	0.000802	CcSEcCtD
Amantadine—GRIN2D—Alzheimers Disease—TNF—migraine	9.67e-05	0.00453	CbGpPWpGaD
Amantadine—Oedema—Topiramate—migraine	9.61e-05	0.000796	CcSEcCtD
Amantadine—Diarrhoea—Valproic Acid—migraine	9.43e-05	0.000781	CcSEcCtD
Amantadine—Nervous system disorder—Topiramate—migraine	9.43e-05	0.00078	CcSEcCtD
Amantadine—Feeling abnormal—Gabapentin—migraine	9.42e-05	0.000779	CcSEcCtD
Amantadine—Tachycardia—Topiramate—migraine	9.38e-05	0.000777	CcSEcCtD
Amantadine—GRIN1—Spinal Cord Injury—FOS—migraine	9.34e-05	0.00438	CbGpPWpGaD
Amantadine—GRIN1—SIDS Susceptibility Pathways—HTR2A—migraine	9.34e-05	0.00438	CbGpPWpGaD
Amantadine—Skin disorder—Topiramate—migraine	9.34e-05	0.000773	CcSEcCtD
Amantadine—Hyperhidrosis—Topiramate—migraine	9.29e-05	0.000769	CcSEcCtD
Amantadine—SLC22A2—Neuronal System—CACNA1A—migraine	9.21e-05	0.00432	CbGpPWpGaD
Amantadine—Anorexia—Topiramate—migraine	9.16e-05	0.000759	CcSEcCtD
Amantadine—Dizziness—Valproic Acid—migraine	9.11e-05	0.000755	CcSEcCtD
Amantadine—Hypersensitivity—Timolol—migraine	9.04e-05	0.000748	CcSEcCtD
Amantadine—SLC22A2—Transmembrane transport of small molecules—TRPM8—migraine	9.04e-05	0.00424	CbGpPWpGaD
Amantadine—Body temperature increased—Gabapentin—migraine	9.03e-05	0.000748	CcSEcCtD
Amantadine—Hypotension—Topiramate—migraine	8.98e-05	0.000744	CcSEcCtD
Amantadine—DRD2—G alpha (i) signalling events—HTR1D—migraine	8.94e-05	0.00419	CbGpPWpGaD
Amantadine—Asthenia—Timolol—migraine	8.8e-05	0.000729	CcSEcCtD
Amantadine—Vomiting—Valproic Acid—migraine	8.76e-05	0.000725	CcSEcCtD
Amantadine—Insomnia—Topiramate—migraine	8.69e-05	0.00072	CcSEcCtD
Amantadine—Rash—Valproic Acid—migraine	8.69e-05	0.000719	CcSEcCtD
Amantadine—Dermatitis—Valproic Acid—migraine	8.68e-05	0.000719	CcSEcCtD
Amantadine—Pruritus—Timolol—migraine	8.68e-05	0.000719	CcSEcCtD
Amantadine—Headache—Valproic Acid—migraine	8.63e-05	0.000715	CcSEcCtD
Amantadine—Paraesthesia—Topiramate—migraine	8.63e-05	0.000715	CcSEcCtD
Amantadine—SLC22A1—Neuronal System—CACNA1A—migraine	8.58e-05	0.00402	CbGpPWpGaD
Amantadine—Dyspnoea—Topiramate—migraine	8.57e-05	0.000709	CcSEcCtD
Amantadine—Somnolence—Topiramate—migraine	8.55e-05	0.000707	CcSEcCtD
Amantadine—Dyspepsia—Topiramate—migraine	8.46e-05	0.0007	CcSEcCtD
Amantadine—SLC22A1—Transmembrane transport of small molecules—TRPM8—migraine	8.42e-05	0.00395	CbGpPWpGaD
Amantadine—Hypersensitivity—Gabapentin—migraine	8.42e-05	0.000697	CcSEcCtD
Amantadine—Diarrhoea—Timolol—migraine	8.4e-05	0.000695	CcSEcCtD
Amantadine—Decreased appetite—Topiramate—migraine	8.36e-05	0.000692	CcSEcCtD
Amantadine—Gastrointestinal disorder—Topiramate—migraine	8.3e-05	0.000687	CcSEcCtD
Amantadine—DRD2—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	8.3e-05	0.00389	CbGpPWpGaD
Amantadine—Fatigue—Topiramate—migraine	8.29e-05	0.000686	CcSEcCtD
Amantadine—Constipation—Topiramate—migraine	8.22e-05	0.000681	CcSEcCtD
Amantadine—ABCB1—head—migraine	8.21e-05	0.00193	CbGeAlD
Amantadine—Asthenia—Gabapentin—migraine	8.2e-05	0.000679	CcSEcCtD
Amantadine—Nausea—Valproic Acid—migraine	8.19e-05	0.000678	CcSEcCtD
Amantadine—Dizziness—Timolol—migraine	8.11e-05	0.000672	CcSEcCtD
Amantadine—Pruritus—Gabapentin—migraine	8.08e-05	0.000669	CcSEcCtD
Amantadine—GRIN1—BDNF signaling pathway—FOS—migraine	7.97e-05	0.00373	CbGpPWpGaD
Amantadine—GRIN2A—Alzheimers Disease—TNF—migraine	7.94e-05	0.00372	CbGpPWpGaD
Amantadine—Feeling abnormal—Topiramate—migraine	7.92e-05	0.000656	CcSEcCtD
Amantadine—Diarrhoea—Gabapentin—migraine	7.82e-05	0.000647	CcSEcCtD
Amantadine—Vomiting—Timolol—migraine	7.8e-05	0.000646	CcSEcCtD
Amantadine—ABCB1—nervous system—migraine	7.79e-05	0.00183	CbGeAlD
Amantadine—GRIN2B—BDNF signaling pathway—FOS—migraine	7.77e-05	0.00364	CbGpPWpGaD
Amantadine—Rash—Timolol—migraine	7.74e-05	0.00064	CcSEcCtD
Amantadine—Dermatitis—Timolol—migraine	7.73e-05	0.00064	CcSEcCtD
Amantadine—DRD2—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	7.71e-05	0.00361	CbGpPWpGaD
Amantadine—Headache—Timolol—migraine	7.69e-05	0.000636	CcSEcCtD
Amantadine—Body temperature increased—Topiramate—migraine	7.6e-05	0.000629	CcSEcCtD
Amantadine—Dizziness—Gabapentin—migraine	7.56e-05	0.000625	CcSEcCtD
Amantadine—ABCB1—central nervous system—migraine	7.5e-05	0.00176	CbGeAlD
Amantadine—DRD2—GPCR ligand binding—CALCRL—migraine	7.45e-05	0.00349	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—RAMP1—migraine	7.45e-05	0.00349	CbGpPWpGaD
Amantadine—ABCB1—cerebellum—migraine	7.33e-05	0.00172	CbGeAlD
Amantadine—Nausea—Timolol—migraine	7.29e-05	0.000603	CcSEcCtD
Amantadine—Vomiting—Gabapentin—migraine	7.26e-05	0.000601	CcSEcCtD
Amantadine—Rash—Gabapentin—migraine	7.2e-05	0.000596	CcSEcCtD
Amantadine—Dermatitis—Gabapentin—migraine	7.2e-05	0.000596	CcSEcCtD
Amantadine—Headache—Gabapentin—migraine	7.16e-05	0.000593	CcSEcCtD
Amantadine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	7.11e-05	0.00333	CbGpPWpGaD
Amantadine—Hypersensitivity—Topiramate—migraine	7.08e-05	0.000586	CcSEcCtD
Amantadine—GRIN1—Alzheimers Disease—TNF—migraine	6.92e-05	0.00325	CbGpPWpGaD
Amantadine—Asthenia—Topiramate—migraine	6.9e-05	0.000571	CcSEcCtD
Amantadine—SLC22A2—Transmembrane transport of small molecules—ATP1A2—migraine	6.85e-05	0.00321	CbGpPWpGaD
Amantadine—SLC22A2—Transmembrane transport of small molecules—ATP1A3—migraine	6.85e-05	0.00321	CbGpPWpGaD
Amantadine—Pruritus—Topiramate—migraine	6.8e-05	0.000563	CcSEcCtD
Amantadine—Nausea—Gabapentin—migraine	6.79e-05	0.000562	CcSEcCtD
Amantadine—GRIN2B—Alzheimers Disease—TNF—migraine	6.75e-05	0.00316	CbGpPWpGaD
Amantadine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	6.61e-05	0.0031	CbGpPWpGaD
Amantadine—Diarrhoea—Topiramate—migraine	6.58e-05	0.000544	CcSEcCtD
Amantadine—SLC22A1—Transmembrane transport of small molecules—ATP1A3—migraine	6.38e-05	0.00299	CbGpPWpGaD
Amantadine—SLC22A1—Transmembrane transport of small molecules—ATP1A2—migraine	6.38e-05	0.00299	CbGpPWpGaD
Amantadine—Dizziness—Topiramate—migraine	6.36e-05	0.000526	CcSEcCtD
Amantadine—Vomiting—Topiramate—migraine	6.11e-05	0.000506	CcSEcCtD
Amantadine—Rash—Topiramate—migraine	6.06e-05	0.000502	CcSEcCtD
Amantadine—Dermatitis—Topiramate—migraine	6.06e-05	0.000501	CcSEcCtD
Amantadine—Headache—Topiramate—migraine	6.02e-05	0.000499	CcSEcCtD
Amantadine—ABCB1—brain—migraine	5.95e-05	0.0014	CbGeAlD
Amantadine—SLC22A2—Transmembrane transport of small molecules—HTR3A—migraine	5.82e-05	0.00273	CbGpPWpGaD
Amantadine—DRD2—Circadian rythm related genes—NPS—migraine	5.82e-05	0.00273	CbGpPWpGaD
Amantadine—Nausea—Topiramate—migraine	5.71e-05	0.000473	CcSEcCtD
Amantadine—DRD2—Circadian rythm related genes—SLC6A4—migraine	5.71e-05	0.00267	CbGpPWpGaD
Amantadine—SLC22A1—Transmembrane transport of small molecules—HTR3A—migraine	5.43e-05	0.00254	CbGpPWpGaD
Amantadine—DRD2—G alpha (i) signalling events—HTR1B—migraine	5.42e-05	0.00254	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—HTR1D—migraine	5.41e-05	0.00254	CbGpPWpGaD
Amantadine—DRD2—G alpha (i) signalling events—HTR1A—migraine	5.21e-05	0.00244	CbGpPWpGaD
Amantadine—DDC—Metabolism—CACNA1A—migraine	5.19e-05	0.00243	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—HTR2B—migraine	5.03e-05	0.00236	CbGpPWpGaD
Amantadine—DRD2—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	5.03e-05	0.00236	CbGpPWpGaD
Amantadine—GRIN1—Spinal Cord Injury—TNF—migraine	5.02e-05	0.00235	CbGpPWpGaD
Amantadine—DRD2—Circadian rythm related genes—HTR7—migraine	5e-05	0.00234	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—TRPM8—migraine	4.94e-05	0.00231	CbGpPWpGaD
Amantadine—DRD2—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	4.84e-05	0.00227	CbGpPWpGaD
Amantadine—DDC—SIDS Susceptibility Pathways—TNF—migraine	4.68e-05	0.00219	CbGpPWpGaD
Amantadine—DRD2—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	4.67e-05	0.00219	CbGpPWpGaD
Amantadine—DRD2—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	4.54e-05	0.00213	CbGpPWpGaD
Amantadine—MAOB—Metabolism—CACNA1A—migraine	4.37e-05	0.00205	CbGpPWpGaD
Amantadine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	4.31e-05	0.00202	CbGpPWpGaD
Amantadine—ABCB1—HIF-1-alpha transcription factor network—FOS—migraine	4.22e-05	0.00198	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—RAMP1—migraine	4.21e-05	0.00197	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—CALCRL—migraine	4.21e-05	0.00197	CbGpPWpGaD
Amantadine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	4.14e-05	0.00194	CbGpPWpGaD
Amantadine—DRD2—GPCRs, Class A Rhodopsin-like—HTR7—migraine	4.09e-05	0.00192	CbGpPWpGaD
Amantadine—DRD2—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	4.08e-05	0.00191	CbGpPWpGaD
Amantadine—DRD2—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	4.08e-05	0.00191	CbGpPWpGaD
Amantadine—GRIN1—SIDS Susceptibility Pathways—TNF—migraine	4.02e-05	0.00188	CbGpPWpGaD
Amantadine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	4e-05	0.00188	CbGpPWpGaD
Amantadine—DRD2—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	3.89e-05	0.00183	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—CALCRL—migraine	3.82e-05	0.00179	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—RAMP1—migraine	3.82e-05	0.00179	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—ATP1A2—migraine	3.74e-05	0.00175	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—ATP1A3—migraine	3.74e-05	0.00175	CbGpPWpGaD
Amantadine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	3.51e-05	0.00164	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—HTR1B—migraine	3.28e-05	0.00154	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—HTR3A—migraine	3.18e-05	0.00149	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—HTR1A—migraine	3.16e-05	0.00148	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—TAC1—migraine	3.11e-05	0.00146	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—NPS—migraine	3.11e-05	0.00146	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—HTR1D—migraine	3.06e-05	0.00143	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—HTR2C—migraine	3.05e-05	0.00143	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—EDNRA—migraine	2.97e-05	0.00139	CbGpPWpGaD
Amantadine—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	2.87e-05	0.00134	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—CALCA—migraine	2.85e-05	0.00134	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—HTR2B—migraine	2.84e-05	0.00133	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—HTR1D—migraine	2.78e-05	0.0013	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—migraine	2.67e-05	0.00125	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—HTR7—migraine	2.67e-05	0.00125	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—HTR2B—migraine	2.58e-05	0.00121	CbGpPWpGaD
Amantadine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	2.46e-05	0.00115	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—CACNA1A—migraine	2.32e-05	0.00109	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—RAMP1—migraine	2.26e-05	0.00106	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CALCRL—migraine	2.26e-05	0.00106	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—CACNA1A—migraine	2.16e-05	0.00101	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—migraine	2e-05	0.000939	CbGpPWpGaD
Amantadine—ABCB1—Allograft Rejection—TNF—migraine	1.97e-05	0.000922	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—HTR2A—migraine	1.87e-05	0.000876	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—HTR1B—migraine	1.85e-05	0.000868	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—HTR1A—migraine	1.78e-05	0.000836	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—TAC1—migraine	1.76e-05	0.000823	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—NPS—migraine	1.76e-05	0.000823	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—HTR2C—migraine	1.72e-05	0.000807	CbGpPWpGaD
Amantadine—DDC—Metabolism—MTHFR—migraine	1.72e-05	0.000805	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—HTR1B—migraine	1.68e-05	0.000789	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—EDNRA—migraine	1.68e-05	0.000785	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—HTR1D—migraine	1.64e-05	0.000769	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—HTR1A—migraine	1.62e-05	0.000759	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—CALCA—migraine	1.61e-05	0.000756	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—TNF—migraine	1.6e-05	0.000749	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—TAC1—migraine	1.6e-05	0.000748	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—NPS—migraine	1.6e-05	0.000748	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—HTR2C—migraine	1.56e-05	0.000733	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—TNF—migraine	1.56e-05	0.00073	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—HTR2B—migraine	1.53e-05	0.000715	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—EDNRA—migraine	1.52e-05	0.000713	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—HTR7—migraine	1.51e-05	0.000707	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—CALCA—migraine	1.46e-05	0.000687	CbGpPWpGaD
Amantadine—MAOB—Metabolism—MTHFR—migraine	1.45e-05	0.000678	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—HTR7—migraine	1.37e-05	0.000642	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—LRP1—migraine	1.34e-05	0.000629	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CACNA1A—migraine	1.27e-05	0.000594	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—HTR2A—migraine	1.06e-05	0.000495	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—NOTCH4—migraine	1.03e-05	0.000483	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—HTR1B—migraine	9.94e-06	0.000466	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—migraine	9.7e-06	0.000455	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—HTR2A—migraine	9.6e-06	0.00045	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—HTR1A—migraine	9.57e-06	0.000448	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—TAC1—migraine	9.42e-06	0.000442	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—NPS—migraine	9.42e-06	0.000442	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PGR—migraine	9.42e-06	0.000442	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—HTR2C—migraine	9.24e-06	0.000433	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—EDNRA—migraine	8.99e-06	0.000421	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—NOTCH3—migraine	8.76e-06	0.000411	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CALCA—migraine	8.65e-06	0.000406	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—HTR7—migraine	8.09e-06	0.000379	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—MTHFR—migraine	7.67e-06	0.00036	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—MTHFR—migraine	7.15e-06	0.000335	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—TGFBR2—migraine	6.97e-06	0.000327	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—HTR2A—migraine	5.67e-06	0.000266	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—ESR1—migraine	5.03e-06	0.000236	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—MTHFR—migraine	4.19e-06	0.000196	CbGpPWpGaD
